Gapping up
In reaction to strong earnings/guidance: INTC +4.8%, TXT +3.3%, ABT +2%, BLK +1.3%, USB +1%, CSX +0.5%.
M&A news: ZIPR +118.5% (Realogy announces agreement to acquire ZipRealty for $6.75/share in an all-cash transaction valued at ~$166 mln), TWX +16.9% (FOXA confirms TWX proposal, which TWX rejected; FOXA says 'We are not currently in any discussions with Time Warner'), IGT +9.4% (enters into definitive merger agreement with GTECH S.p.A. (GTKYY)), ICAD +5.2% (acquired DermEbx and Radion to provide skin cancer treatment solution to the dermatology market; expected to be immediately accretive to revs and operating cash flow), FOXA +0.6% ( confirms TWX proposal, which TWX rejected; FOXA says 'We are not currently in any discussions with Time Warner'), .
Other news: OIBR +17.6% (signed MOU with Portugal Telecom (PT) in relation to financial investments in Rio Forte Investments S.A. commercial paper), CNCE +8.3% (announces FDA lifts partial clinical hold for CTP-354, a novel drug candidate for spasticity), PDS +4.5% (announces strategic technology and service agreement & marketing alliance with Schlumberger (SLB)), GLW +4.3% (Potential catalysts: BGR report out yesterday afternoon highlighted Gorilla Glass vs Sapphire), PT +3.9% (signed MOU with OIBR) in relation to financial investments in Rio Forte Investments S.A. commercial paper), STM +3.8% (following INTC earnings), BLRX +3.4% (announces results from phase 1/2 study for Celiac treatment), GPRO +3.1% (seeing continued strength), CY +2.8% (following INTC results), ARNA +2.4% (issued patent for APD371 by USPTO), SUNE +2.4% (trading higher ahead of TerraForm Power (TERP) IPO), AAPL +2.2% (Apple and IBM announce exclusive partnership to transform enterprise mobility through a new class of business apps ), AMD +2.2% (following INTC earnings), IBM +2% (Apple and IBM announce exclusive partnership to transform enterprise mobility through a new class of business apps ), JKS +2% (signs RMB1 bln strategic financing agreement with China Minsheng Bank), RIO +1.9% (reports record first half iron ore shipments), ISIS +1.8% (earns $1 million from GlaxoSmithKline for advancing ISIS-TTR Rx), MT +1.7% (bte China GDP), CBS +1.7% (open to licensing agreement with Aereo, according to reports), KNDI+1.7% (seeing continued strength), SIRI +1.5% (announces additional $2 billion common stock repurchase program).
Analyst comments: TNDM +12.1% (initiated with an Outperform at William Blair), FEYE +5.1% (assumed with a Buy from Neutral at Goldman), MLNX +3.9% (upgraded to Buy from Hold at Jefferies), PANW +3.3% (assumed with a Buy at Goldman), ARMH +2.4% (upgraded to Buy from Hold at FinnCap), WDC +2% (upgraded to Outperform at Robert W. Baird ), IM +1.9% (upgraded to Buy from Neutral at BofA/Merrill ), SJW +1.5% (upgraded to Outperform at Robert W. Baird), SYT +1.1% (upgraded to Outperform from Neutral at Credit Suisse), AAL +0.7% (initiated with a Overweight at Atlantic Equities)
In reaction to strong earnings/guidance: INTC +4.8%, TXT +3.3%, ABT +2%, BLK +1.3%, USB +1%, CSX +0.5%.
M&A news: ZIPR +118.5% (Realogy announces agreement to acquire ZipRealty for $6.75/share in an all-cash transaction valued at ~$166 mln), TWX +16.9% (FOXA confirms TWX proposal, which TWX rejected; FOXA says 'We are not currently in any discussions with Time Warner'), IGT +9.4% (enters into definitive merger agreement with GTECH S.p.A. (GTKYY)), ICAD +5.2% (acquired DermEbx and Radion to provide skin cancer treatment solution to the dermatology market; expected to be immediately accretive to revs and operating cash flow), FOXA +0.6% ( confirms TWX proposal, which TWX rejected; FOXA says 'We are not currently in any discussions with Time Warner'), .
Other news: OIBR +17.6% (signed MOU with Portugal Telecom (PT) in relation to financial investments in Rio Forte Investments S.A. commercial paper), CNCE +8.3% (announces FDA lifts partial clinical hold for CTP-354, a novel drug candidate for spasticity), PDS +4.5% (announces strategic technology and service agreement & marketing alliance with Schlumberger (SLB)), GLW +4.3% (Potential catalysts: BGR report out yesterday afternoon highlighted Gorilla Glass vs Sapphire), PT +3.9% (signed MOU with OIBR) in relation to financial investments in Rio Forte Investments S.A. commercial paper), STM +3.8% (following INTC earnings), BLRX +3.4% (announces results from phase 1/2 study for Celiac treatment), GPRO +3.1% (seeing continued strength), CY +2.8% (following INTC results), ARNA +2.4% (issued patent for APD371 by USPTO), SUNE +2.4% (trading higher ahead of TerraForm Power (TERP) IPO), AAPL +2.2% (Apple and IBM announce exclusive partnership to transform enterprise mobility through a new class of business apps ), AMD +2.2% (following INTC earnings), IBM +2% (Apple and IBM announce exclusive partnership to transform enterprise mobility through a new class of business apps ), JKS +2% (signs RMB1 bln strategic financing agreement with China Minsheng Bank), RIO +1.9% (reports record first half iron ore shipments), ISIS +1.8% (earns $1 million from GlaxoSmithKline for advancing ISIS-TTR Rx), MT +1.7% (bte China GDP), CBS +1.7% (open to licensing agreement with Aereo, according to reports), KNDI+1.7% (seeing continued strength), SIRI +1.5% (announces additional $2 billion common stock repurchase program).
Analyst comments: TNDM +12.1% (initiated with an Outperform at William Blair), FEYE +5.1% (assumed with a Buy from Neutral at Goldman), MLNX +3.9% (upgraded to Buy from Hold at Jefferies), PANW +3.3% (assumed with a Buy at Goldman), ARMH +2.4% (upgraded to Buy from Hold at FinnCap), WDC +2% (upgraded to Outperform at Robert W. Baird ), IM +1.9% (upgraded to Buy from Neutral at BofA/Merrill ), SJW +1.5% (upgraded to Outperform at Robert W. Baird), SYT +1.1% (upgraded to Outperform from Neutral at Credit Suisse), AAL +0.7% (initiated with a Overweight at Atlantic Equities)